Skip to main content
. 2018 Jul 6;38(4):BSR20180214. doi: 10.1042/BSR20180214

Table 2. The interest outcomes extracted from included studies.

Study HR HR HR OR OR
(95% CI) for OS (95% CI) for CSS (95% CI) for RFS (95% CI) for 30dC (95% CI) for 90dM
Caras et al. (2017) NA NA NA 3.14 (2.86, 3.45) (overall morbidity)* 7.66 (5.80, 10.12) (overall morbidity)*
1.85 (1.41, 2.44) (RC)* 1.71 (0.85, 3.45) (RC)*
4.32 (3.47, 5.39) (TURBT)* 9.89 (6.05, 16.16)(TURBT)*
Chan et al. (2013) NA 1.79 (0.78, 4.08)* NA NA NA
Cho et al. (2014) 0.60 (0.26–1.39) NA 2.88 (1.80–4.62) NA NA
Cui et al. (2017) 5.509 (2.144–14.158) 5.521 (2.074–14.697) NA NA NA
Djaladat et al. (2014) 1.93 (1.43–2.63) NA 1.68 (1.16–2.43) 1.41 (0.98–2.02) 2.42 (1.31, 4.45)*
Fujita et al. (2015) 2.63 (1.149, 6.02) 2.63 (5.882, 1.149)
Garg et al. (2014) NA 1.68 (1.17, 2.41) 3.03 (7.143, 1.33)
Hinata et al. (2015) 1.062 (0.643–1.703) NA 1.077 (0.654–1.718) NA NA
Huang et al. (2017) 1.96 (0.96–4.01) 2.51 (1.22–5.18) NA NA NA
Johnson et al. (2015) NA NA NA 1.79 (1.06, 3.03) NA
Kluth et al. (2014) NA 1.754 (1.2987, 2.326) NA NA NA
Krane et al. (2013) 4.96 (2.18–11.67) 8.10 (2.63–27.59) NA NA NA
Ku et al. (2015) 1.670 (1.007–2.767) 1.794 (1.010–3.187) NA NA NA
Lambert et al. (2013) 1.76 (1.03, 2.12)* 1.57 (1.24, 1.90)* NA 3.9 (1.3–12.2) 22.96 (2.47, 213.36)*
Laurent et al. (2017) 3.06 (1.81–5.17) NA NA NA NA
Lavallee et al. (2014) NA NA NA 1.16 (1.06–1.26) NA
Liu et al. (2016) NA 0.979 (0.880–1.089) 0.998 (0.908–1.096) NA NA
Morgan et al. (2011) NA NA NA NA 2.50 (1.40–4.45)
Mursi et al. (2013) NA NA NA NA 9.20 (0.69, 122.38)*
Nakagawa et al. (2017) 1.51 (0.95–2.41) NA NA NA NA
Sharma et al. (2016) NA NA NA 2.27 (5.56, 0.94) NA
Sheth et al. (2016) 3.37 (1.43–7.92) NA 4.4 (2.04–9.30) NA NA
Taguchi et al. (2016) 1.345 (0.969–1.855) NA NA NA NA

Abbreviation: NA, not available; TURBT, transurethral resection of bladder tumor.

*Data extracted indirectly.